Jan 14, 2020 / 06:30PM GMT
Tycho W. Peterson - JP Morgan Chase & Co, Research Division - Senior Analyst
Okay. We're going to go ahead and get started. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this morning, Intuitive Surgical. We'll do a breakout right after in the Georgian room, which is across the hall.
With that, let me turn it over to Gary.
Gary S. Guthart - Intuitive Surgical, Inc. - CEO & Director
Good morning. Tycho, thank you. Appreciate the opportunity to speak to you today. We will take you through some forward looking statements and some estimates. We'll also show you some things that we're working on that are not yet cleared for use in the United States, or in some cases, other parts of the world, I highly encourage you to look at our SEC filings and our website.
Let me start with why we do what we do, kind of what's our motive force. For those of you who know a little bit about surgery. The reality is, it's important. It's an important tool in treatment and it's hard and highly variable. If you
Intuitive Surgical Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
